As of June 6, 2025, Chembio Diagnostics Inc (CEMI) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Chembio Diagnostics Inc's Forward P/E to Peers
To better understand Chembio Diagnostics Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Chembio Diagnostics Inc (CEMI) | - |
| Figs Inc (FIGS) | 99.80 |
| Antares Pharma Inc (ATRS) | 51.85 |
| West Pharmaceutical Services Inc (WST) | 33.71 |
| ICU Medical Inc (ICUI) | 19.83 |
| Cooper Companies Inc (COO) | 19.08 |
Compared to its competitors, Chembio Diagnostics Inc's Forward P/E is difficult to compare due to insufficient data.